For informational purposes only — not investment advice

← Back to signals

LIN

SHORTINSIDER SELL

LINDE PLC

Research: Finviz ↗·Perplexity ↗

Funds
3
Score
3.45
vs SPY
+13.6%
Stock return (since Q-end)
+7.5%
SPY return (since Q-end)
-6.1%
Current price
$510.21
Days to cover (short int.)
3.4d↑+11.1%
as of 2026-10-30 · shares short vs 2026-09-30

News Summary

Positive

Linde delivered a strong Q3 2026 earnings beat with record sales of $9.4B (+9% YoY) and adjusted EPS of $4.59 (9% above prior year), exceeding both revenue and EPS estimates. However, the company took a $425M restructuring charge and is evaluating strategic alternatives for its underperforming Lincare healthcare business, which now reports separately for transparency purposes.

Red flags

  • •Lincare underperformance and strategic review uncertainty—potential sale could create execution risk and distract management
  • •$425M restructuring charge signals operational challenges requiring significant restructuring
  • •Reported diluted EPS down 11% YoY ($3.66 actual vs. $4.59 adjusted), indicating material non-recurring charges

Funds Reducing / Exiting (3)

FundManagerShares Held∆ SharesPosition Value% of FundQoQStatus
Soros Fund ManagementSoros Family Office78K-189,698$37M2.3%-71%Existing
Lone Pine CapitalSteve Mandel0−1.6M—4.9%-100%EXITED
Duquesne Family OfficeStanley Druckenmiller0−41K—0.5%-100%EXITED

Shares Held reflects quarter-end positions for partial reductions. Funds that fully exited show 0 shares held. ∆ Shares is the change from the prior quarter. % of Fund is the prior-quarter position size — how much of the book was sold down.

Signal History

QuarterDirectionFundsScorevs SPY
Q3 2026SHORT33.45+13.6%
Q2 2026LONG34.36+1.9%
Q1 2026LONG45.50-22.0%

Same issuer appearing in consecutive quarters — persistent institutional conviction. Returns are frozen at each archived quarter's last refresh.

Insider Activity

NameTitleTypeSharesPriceValueFiledSrc
White Matthew JChief Financial OfficerSELL16K$524.25$8.22M2026-11-04↗
White Matthew JChief Financial OfficerSELL30K$518.50$15.60M2026-11-04↗
White Matthew JChief Financial OfficerSELL24K$520.00$12.68M2026-11-04↗
White Matthew JChief Financial OfficerSELL17K$525.00$8.75M2026-11-04↗
Bichara GuillermoExec VP & Chief Legal OfficerSELL9K$518.91$4.85M2026-11-02↗

Congressional Trading

No trades dated since Jul 1, 2026.

Earlier trades (1) — dated outside this quarter's window, not counted in the badges
MemberChamberStateTypeAmount RangeTransaction DateFiledSrc
Alan Armstrongsenate—SELL$15,001 - $50,0002026-03-272026-07-21↗

Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures. Members often file weeks or months after trading, so trades are placed by transaction date: the badges above count trades dated since Jul 1, 2026.